Corcept Therapeutics Incorporated (CORT)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 506,705 | 501,842 | 375,806 | 523,338 | 371,182 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $506,705K)
= 0.00
The debt-to-capital ratio for Corcept Therapeutics Inc has consistently been 0.00 for the past five years, from 2019 to 2023. This indicates that the company has not relied on debt financing to fund its operations or growth, and instead has mainly relied on equity financing. A debt-to-capital ratio of 0.00 signifies that the company has no debt in its capital structure, resulting in a lower financial risk profile as there are no interest payments to be made. However, it is important to note that while a low debt-to-capital ratio can be favorable in terms of financial risk, it may also suggest limited leverage and potential constraints on the company's ability to take advantage of growth opportunities that could be funded through debt. Overall, the stable and consistently low debt-to-capital ratio for Corcept Therapeutics Inc reflects a conservative financial strategy that prioritizes equity financing over debt.
Peer comparison
Dec 31, 2023